Vertex Pharmaceuticals
VRTX
VRTX
411 hedge funds and large institutions have $21.7B invested in Vertex Pharmaceuticals in 2014 Q2 according to their latest regulatory filings, with 58 funds opening new positions, 136 increasing their positions, 162 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
4% more funds holding
Funds holding: 395 → 411 (+16)
16% less repeat investments, than reductions
Existing positions increased: 136 | Existing positions reduced: 162
Holders
411
Holding in Top 10
6
Calls
$910M
Puts
$724M
Top Buyers
| 1 | +$608M | |
| 2 | +$193M | |
| 3 | +$192M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$147M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$124M |
Top Sellers
| 1 | -$120M | |
| 2 | -$112M | |
| 3 | -$100M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$99.1M |
| 5 |
D.E. Shaw & Co
New York
|
-$92.2M |